Cite
HARVARD Citation
Wanderling, C. et al. (2017). Dysregulation of Tissue Factor, Thrombin-Activatable Fibrinolysis Inhibitor, and Fibrinogen in Patients Undergoing Total Joint Arthroplasty. Clinical and applied thrombosis/hemostasis. pp. 967-972. [Online].